RxNorm Semantic Concepts Index - 598
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "598".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 598 | Prostaglandin PGE1 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 598 | Prostaglandin PGE1 | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 598 | Prostaglandin PGE1 | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 598 | Prostaglandin PGE1 | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 598 | Prostaglandin PGE1 | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 598 | Prostaglandin PGE1 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 598 | Prostaglandin PGE1 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 598000 | Ammonul | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 598006 | erythromycin 250 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 598006 | erythromycin 250 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 598008 | Erythromycin 250 mg oral capsule | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 598008 | Erythromycin 250 mg oral capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 598008 | Erythromycin 250 mg oral capsule | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 598012 | interferon alfa-n3 5000000 UNT/ML [Alferon N] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 598013 | interferon alfa-n3 Injectable Solution [Alferon N] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 598014 | Alferon N 5,000,000 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 598014 | Alferon N 5,000,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 598014 | Alferon N 5,000,000 UNT/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 598022 | Zmax | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 598023 | Tetradure | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 598025 | amoxicillin 250 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 598025 | amoxicillin 250 MG Chewable Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 598025 | amoxicillin 250 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 598025 | amoxicillin 250 MG Chewable Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 598031 | FLUoxetine Delayed Release Oral Capsule [PROzac] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 598031 | FLUoxetine Delayed Release Oral Capsule [PROzac] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 598032 | PROzac Weekly 90 MG Delayed Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 598032 | PROzac Weekly 90 MG Delayed Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 598032 | PROzac Weekly 90 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 598032 | PROzac Weekly 90 MG Delayed Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 598032 | PROzac Weekly 90 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 598032 | PROzac Weekly 90 MG Delayed Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 598032 | PROzac Weekly 90 MG Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 598040 | Benzyl Alcohol 0.09 ML/ML / NaCl 0.154 MEQ/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 598040 | Benzyl Alcohol 0.09 ML/ML / NaCl 0.154 MEQ/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 598048 | polyvinyl alcohol 0.005 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 598050 | polyvinyl alcohol 0.5 % / povidone 0.6 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 598050 | polyvinyl alcohol 0.5 % / povidone 0.6 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 598050 | polyvinyl alcohol 0.5 % / povidone 0.6 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 598056 | clemastine fumarate 1.34 MG Oral Tablet [Daily Hist] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 598056 | clemastine fumarate 1.34 MG Oral Tablet [Daily Hist] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 5981 | Iproniazid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 5981 | Iproniazid | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 5981 | Iproniazid | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 5981 | Iproniazid | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 5981 | Iproniazid | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 59816 | Amprotropine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 59816 | Amprotropine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 5982 | Ipronidazole | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 5982 | Ipronidazole | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 5982 | Ipronidazole | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 5982 | Ipronidazole | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 59827 | tirilazad mesylate hydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 59832 | Hb 86(F2), Ala-asp | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 59832 | Hb 86(F2), Ala-asp | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 59832 | Hb 86(F2), Ala-asp | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 59832 | Hb 86(F2), Ala-asp | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 59833 | Hb 88(F4), Leu-arg | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 59833 | Hb 88(F4), Leu-arg | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 59833 | Hb 88(F4), Leu-arg | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 59833 | Hb 88(F4), Leu-arg | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 59838 | halazone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 59839 | penciclovir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 59839 | penciclovir | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 59839 | penciclovir | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 59839 | penciclovir | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 59839 | penciclovir | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 59857 | Hb 53(E2), Ala-asp | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 59857 | Hb 53(E2), Ala-asp | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 59857 | Hb 53(E2), Ala-asp | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 59857 | Hb 53(E2), Ala-asp | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 59860 | chlorproethazine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 59877 | Succinyldiaminopimelate desuccinylase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 59877 | Succinyldiaminopimelate desuccinylase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 59880 | Hb 66(E10), Lys-thr | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 59880 | Hb 66(E10), Lys-thr | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 59880 | Hb 66(E10), Lys-thr | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 59880 | Hb 66(E10), Lys-thr | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 59897 | Brown recluse spider venom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 59897 | Brown recluse spider venom | Full form of descriptor (FN) | NO |